She highlights the emergence of axatilimab, a CSF-1R inhibitor that attacks the underlying mechanisms of cGVHD by targeting ...
Based on the positive global Phase III MANEUVER study, the National Medical Products Administration (NMPA) has granted the ...
We have only just started to understand how our brains clean themselves, but columnist Helen Thomson finds promising evidence ...
Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) by inhibiting semaphorin 4D (SEMA4D) induced pathology in brain, ...
Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...
Researchers have discovered a brain enzyme that could lead to new treatments for neurodegenerative diseases by restoring ...
In early Nov, Minister Sunil Hadunhetti stated in Parliament that beneficiaries of the Aswesuma program should be ashamed for ...
The Vancouver school board has voted to permanently close Sir Guy Carleton Elementary, which has been sitting vacant for ...
An update from Gain Therapeutics ( ($GANX) ) is now available. On December 18, 2025, Gain Therapeutics reported exploratory endpoint data from ...
The Zen Parent on MSN
Alzheimer's may actually begin with an infected gum
Scientists have long been stumped by the neurodegenerative condition, Alzheimer's disease, and have been working to ...
NEW RESEARCH has shown that Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is linked to simultaneous disruptions in energy metabolism, immune regulation, and vascular function. Australian ...
We spoke with multiple experts to discuss the challenges and developments in diagnosing Ehlers-Danlos Syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results